STREPTOCOCCUS FOR USE IN THE TREATMENT OF GLUCOSE INTOLERANCE
Number of patents in Portfolio can not be more than 2000
United States of America
Stats
-
N/A
Issued Date -
Mar 6, 2025
app pub date -
Oct 6, 2021
filing date -
Oct 6, 2021
priority date (Note) -
Published
status (Latency Note)
Importance
Abstract
The present invention relates to an inactivated streptococcus, or a membrane fraction derived therefrom, the streptococcus being obtained from a streptococcus comprising a gene encoding a 16S ribosomal RNA, the gene comprising a nucleotide sequence consisting of the sequence SEQ ID NO: 1, for use in a therapeutic method for preventing and/or treating glucose intolerance and/or a disease associated with glucose intolerance in an individual in need thereof.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully